Why is Glenmark Pharmaceuticals Ltd. ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.67 times
2
Poor long term growth as Net Sales has grown by an annual rate of 6.27% over the last 5 years
3
The company declared negative results in Sep'26 after flat results in Jun'26
- INTEREST(Latest six months) At Rs 117.77 cr has Grown at 40.15%
- OPERATING PROFIT TO INTEREST(Q) Lowest at 13.55 times
- PBT LESS OI(Q) At Rs 619.63 cr has Fallen at -37.7% (vs previous 4Q average)
4
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 09-Nov-26 and has generated -1.19% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST, DOW and OBV
5
With ROE of 18.7, it has a Fair valuation with a 6.7 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 40.73%, its profits have fallen by -6.5%
6
High Institutional Holdings at 39.18%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you hold?
- Overall Portfolio exposure to Glenmark Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Glenmark Pharma for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Glenmark Pharma
40.73%
1.38
29.60%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
6.27%
EBIT Growth (5y)
8.55%
EBIT to Interest (avg)
7.82
Debt to EBITDA (avg)
1.24
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
1.16
Tax Ratio
23.76%
Dividend Payout Ratio
6.74%
Pledged Shares
0
Institutional Holding
39.18%
ROCE (avg)
19.98%
ROE (avg)
12.04%
Valuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
40
Price to Book Value
6.67
EV to EBIT
28.30
EV to EBITDA
22.68
EV to Capital Employed
6.61
EV to Sales
4.70
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
23.35%
ROE (Latest)
18.75%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Bullish
OBV
Bullish
Bullish
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-18What is not working for the Company
INTEREST(Latest six months)
At Rs 117.77 cr has Grown at 40.15%
OPERATING PROFIT TO INTEREST(Q)
Lowest at 13.55 times
PBT LESS OI(Q)
At Rs 619.63 cr has Fallen at -37.7% (vs previous 4Q average
PAT(Q)
At Rs 485.18 cr has Fallen at -37.4% (vs previous 4Q average
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.86 times
EPS(Q)
Lowest at Rs 9.35
Loading Valuation Snapshot...
Here's what is not working for Glenmark Pharma
Operating Profit to Interest - Quarterly
Lowest at 13.55 times and Fallen
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 619.63 cr has Fallen at -37.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 993.87 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 485.18 cr has Fallen at -37.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 775.31 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Latest six months
At Rs 117.77 cr has Grown at 40.15%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 9.35
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Lowest at 2.86 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio